Anna Kioumi

Genetic hyperferritinaemia and reticuloendothelial iron overload associated with a three base pair deletion in the coding region of the ferroportin gene (<i>SLC11A3</i>)

Mario Cazzola, Laura Cremonesi, Maria Papaioannou et al. · British Journal of Haematology · 2002 · 91 citations

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience

Eirini Katodritou, Evangelos Terpos, Efstathios Kastritis et al. · Annals of Hematology · 2015 · 54 citations

Hematological Malignancy, Neuro-oncology, Novel Anti-myeloma Agents +8

Correlations of JAK2–V617F mutation with clinical and laboratory findings in patients with myeloproliferative disorders

Matthaios Speletas, Eirini Katodritou, Chrisoula Daiou et al. · Leukemia Research · 2006 · 52 citations

Hematological Malignancy, Jak2–v617f Mutation, Jak-stat Signaling Pathway +10

Analysis of SLC40A1 gene at the mRNA level reveals rapidly the causative mutations in patients with hereditary hemochromatosis type IV

Matthaios Speletas, Anna Kioumi, Gedeon Loules et al. · Blood Cells Molecules and Diseases · 2007 · 24 citations

Mrna Level Reveals, Allelic Variant, Genetic Disorder +10

Real-world data on Len/Dex combination at second-line therapy of multiple myeloma: treatment at biochemical relapse is a significant prognostic factor for progression-free survival

Eirini Katodritou, Marie‐Christine Kyrtsonis, Sosana Delimpasi et al. · Annals of Hematology · 2018 · 20 citations · Full text